IL13 and breast cancer: Median levels of ANG, ANGST, 8-iso-PGF2α, SNCG, and IL-13 were 12-fold, 6.6-fold, 1.5-fold, 1.2-fold, and 1.9-fold higher, respectively, in the HG subgroup of BC patients compared with the control group.